--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About SION20260515C35
Pharmaceutical
Sionna Therapeutics, Inc., was incorporated under the laws of the State of Delaware in August 2019. The company is a clinical-stage biopharmaceutical company whose mission is to revolutionize the current treatment model for cystic fibrosis patients by developing new drugs that normalize the function of cystic fibrosis transmembrane conductance regulator proteins and provide clinically meaningful benefits to patients with CF.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
